litlas
ログインアカウント作成

Geoffrey A. Block

1990–2025 年に発表

76
論文数
20,881
被引用数
57
h 指数
75
i10 指数

被引用数

Geoffrey A. Block の年別被引用数1978 年: 被引用 1 件1979 年: 被引用 2 件1980 年: 被引用 2 件1984 年: 被引用 3 件1985 年: 被引用 3 件1986 年: 被引用 4 件1987 年: 被引用 3 件1988 年: 被引用 1 件1989 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 2 件1993 年: 被引用 4 件1994 年: 被引用 1 件1995 年: 被引用 7 件1996 年: 被引用 6 件1997 年: 被引用 7 件1998 年: 被引用 15 件1999 年: 被引用 6 件2000 年: 被引用 9 件2001 年: 被引用 16 件2002 年: 被引用 18 件2003 年: 被引用 40 件2004 年: 被引用 50 件2005 年: 被引用 114 件2006 年: 被引用 77 件2007 年: 被引用 141 件2008 年: 被引用 163 件2009 年: 被引用 119 件2010 年: 被引用 119 件2011 年: 被引用 101 件2012 年: 被引用 90 件2013 年: 被引用 127 件2014 年: 被引用 123 件2015 年: 被引用 196 件2016 年: 被引用 167 件2017 年: 被引用 192 件2018 年: 被引用 207 件2019 年: 被引用 777 件2020 年: 被引用 732 件2021 年: 被引用 712 件2022 年: 被引用 597 件2023 年: 被引用 459 件2024 年: 被引用 549 件2025 年: 被引用 229 件2026 年: 被引用 8 件1981〜1983 年は被引用が無いため表示していません1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,090 件、この内訳の 25.9%中国: 引用元論文 703 件、この内訳の 8.7%イギリス: 引用元論文 593 件、この内訳の 7.3%ドイツ: 引用元論文 431 件、この内訳の 5.3%日本: 引用元論文 397 件、この内訳の 4.9%イタリア: 引用元論文 361 件、この内訳の 4.5%カナダ: 引用元論文 285 件、この内訳の 3.5%フランス: 引用元論文 277 件、この内訳の 3.4%オーストラリア: 引用元論文 264 件、この内訳の 3.3%オランダ: 引用元論文 234 件、この内訳の 2.9%スペイン: 引用元論文 227 件、この内訳の 2.8%スウェーデン: 引用元論文 181 件、この内訳の 2.2%
0%25.9%その他 25.3%

機関

分野

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology24.8%
  • Immunology and Microbiology2.4%
  • Nursing1.2%
  • Neuroscience1%
  • Engineering0.7%
  • その他2.3%

トピック

  • Parathyroid Disorders and Treatments9.5%
  • Cancer, Hypoxia, and Metabolism6.2%
  • Dialysis and Renal Disease Management5.5%
  • Magnesium in Health and Disease3.1%
  • Erythropoietin and Anemia Treatment3.1%
  • Iron Metabolism and Disorders2.8%
  • その他69.8%

共著者

全論文

検索で開く
  1. Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients

    著者: Francesco Locatelli, Steven Fishbane, Geoffrey A. Block, Iain C. Macdougall - American Journal of Nephrology 2017 被引用: 4,816

  2. Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters

    著者: Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel, Masafumi Fukagawa, Charles A. Herzog, Linda McCann, Sharon M. Moe, Rukshana Shroff, Marcello Tonelli, Nigel D. Toussaint, Marc Vervloet, Mary B. Leonard - Kidney International 2017 被引用: 1,002

  3. Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis

    著者: Geoffrey A. Block, Preston Klassen, J. Michael Lazarus, Norma J. Ofsthun, Edmund G. Lowrie, Glenn M. Chertow - Journal of the American Society of Nephrology 2004 被引用: 2,690

  4. Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD

    著者: Glenn M. Chertow, Pablo E. Pérgola, Youssef M.K. Farag, Rajiv Agarwal, Susan Arnold, Gabriel Bako, Geoffrey A. Block, Steven K. Burke, Fausto P. Castillo, Alan G. Jardine, Zeeshan Khawaja, Mark J. Koury, Eldrin F. Lewis, Tim Lin, Wei Luo, Bradley J. Maroni, Kunihiro Matsushita, Peter A. McCullough, Patrick S. Parfrey, Prabir Roy‐Chaudhury, Mark J. Sarnak, Amit Sharma, Bruce Spinowitz, Carol Tseng, James A. Tumlin, Dennis Vargo, Kimberly A. Walters, Wolfgang C. Winkelmayer­, Janet Wittes, Kai‐Uwe Eckardt - New England Journal of Medicine 2021 被引用: 238

  5. Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis

    著者: Kai‐Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad, Ahmed Awad, Geoffrey A. Block, Marcelo Rodrigues Bacci, Youssef M.K. Farag, Steven Fishbane, Harold Hubert, Alan G. Jardine, Zeeshan Khawaja, Mark J. Koury, Bradley J. Maroni, Kunihiro Matsushita, Peter A. McCullough, Eldrin F. Lewis, Wei Luo, Patrick S. Parfrey, Pablo E. Pérgola, Mark J. Sarnak, Bruce Spinowitz, James A. Tumlin, Dennis Vargo, Kimberly A. Walters, Wolfgang C. Winkelmayer­, Janet Wittes, Rafał Zwiech, Glenn M. Chertow - New England Journal of Medicine 2021 被引用: 197

  6. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism

    著者: Geoffrey A. Block, David A. Bushinsky, Sunfa Cheng, John Cunningham, Bastian Dehmel, Tilman B. Drüeke, Markus Ketteler, Reshma Kewalramani, Kévin Martin, Sharon M. Moe, Uptal D. Patel, Justin Silver, Yan Sun, Hao Wang, Glenn M. Chertow - JAMA 2017 被引用: 304

  7. Sodium Zirconium Cyclosilicate in Hyperkalemia

    著者: David Packham, Henrik Rasmussen, Philip T. Lavin, Mohamed A. El-Shahawy, Simon D. Roger, Geoffrey A. Block, Wajeh Y. Qunibi, Pablo E. Pérgola, Bhupinder Singh - New England Journal of Medicine 2014 被引用: 493

  8. Effects of Bardoxolone Methyl in Alport Syndrome

    著者: Bradley A. Warady, Pablo E. Pérgola, Rajiv Agarwal, Sharon Andreoli, Gerald B. Appel, Sripal Bangalore, Geoffrey A. Block, Arlene B. Chapman, Melanie Chin, Keisha L. Gibson, Angie Goldsberry, Kazumoto Iijima, Lesley A. Inker, Clifford E. Kashtan, Bertrand Knebelmann, Laura H. Mariani, Colin J. Meyer, Kandai Nozu, Megan O’Grady, Michelle N. Rheault, Arnold L. Silva, Peter Stenvinkel, Roser Torrá, Glenn M. Chertow - Clinical Journal of the American Society of Nephrology 2022 被引用: 46

  9. A single-dose study of denosumab in patients with various degrees of renal impairment

    著者: Geoffrey A. Block, Henry G. Bone, Liang Fang, Edward Lee, Desmond Padhi - Journal of Bone and Mineral Research 2012 被引用: 340

  10. A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)

    著者: Nigel D. Toussaint, Eugenia Pedagogos, Nicole Lioufas, Grahame J. Elder, Elaine M. Pascoe, Sunil V. Badve, Andrea Valks, Geoffrey A. Block, Neil Boudville, James D. Cameron, Katrina L. Campbell, Sylvia S.M. Chen, Randall Faull, S. Holt, Dana Jackson, Meg Jardine, David W. Johnson, Peter G. Kerr, Kenneth K. Lau, Lai Seong Hooi, Om Narayan, Vlado Perkovic, Kevan R. Polkinghorne, Carol A. Pollock, Donna Reidlinger, Laura Robison, Edward R. Smith, Robert Walker, Angela Yee‐Moon Wang, Carmel M. Hawley, IMPROVE-CKD Trial Investigators - Journal of the American Society of Nephrology 2020 被引用: 88

  11. A Longitudinal Study of Uremic Pruritus in Hemodialysis Patients

    著者: Vandana Mathur, Jill S. Lindberg, Michael J. Germain, Geoffrey A. Block, James A. Tumlin, Mark Llewellyn Smith, Mandeep S. Grewal, Dawn McGuire - Clinical Journal of the American Society of Nephrology 2010 被引用: 319

  12. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

    著者: Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel, Masafumi Fukagawa, Charles A. Herzog, Linda McCann, Sharon M. Moe, Rukshana Shroff, Marcello Tonelli, Nigel D. Toussaint, Marc Vervloet, Mary B. Leonard - Annals of Internal Medicine 2018 被引用: 317

  13. Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis

    著者: Sharon M. Moe, Glenn M. Chertow, Patrick S. Parfrey, Yumi Kubo, Geoffrey A. Block, Ricardo Correa‐Rotter, Tilman B. Drüeke, Charles A. Herzog, Gérard M. London, Kenneth W. Mahaffey, David C. Wheeler, Maria Stolina, Bastian Dehmel, William G. Goodman, Jürgen Floege - Circulation 2015 被引用: 304

  14. Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis

    著者: Sharon M. Moe, Safa Abdalla, Glenn M. Chertow, Patrick S. Parfrey, Geoffrey A. Block, Ricardo Correa‐Rotter, Jürgen Floege, Charles A. Herzog, Gérard M. London, Kenneth W. Mahaffey, David C. Wheeler, Bastian Dehmel, William G. Goodman, Tilman B. Drüeke - Journal of the American Society of Nephrology 2014 被引用: 210

  15. Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

    著者: Melanie Chin, George L. Bakris, Geoffrey A. Block, Glenn M. Chertow, Angie Goldsberry, Lesley A. Inker, Hiddo J.L. Heerspink, Megan O’Grady, Pablo E. Pérgola, Christoph Wanner, David G. Warnock, Colin J. Meyer - American Journal of Nephrology 2018 被引用: 161

  16. Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

    著者: Geoffrey A. Block, Kévin Martin, Ángel Francisco, Stewart A. Turner, Morrell M. Avram, Michael Suranyi, Gavril Hercz, John Cunningham, Ali K. Abu‐Alfa, Piergiorgio Messa, Daniel W. Coyne, Francesco Locatelli, Raphael M. Cohen, Pieter Evenepoel, Sharon M. Moe, Albert Fournier, J. Braun, Laura C. McCary, Valter J. Zani, Kurt Olson, Tilman B. Drüeke, William G. Goodman - New England Journal of Medicine 2004 被引用: 1,132

  17. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial

    著者: Andreas Pasch, Geoffrey A. Block, Matthias Bachtler, Edward R. Smith, Wilhelm Jahnen-Dechent, Spyridon Arampatzis, Glenn M. Chertow, Patrick S. Parfrey, Xiaoye Ma, J. Floege - Clinical Journal of the American Society of Nephrology 2016 被引用: 154

  18. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study

    著者: Joshua D. Bundy, Xuan Cai, Julia J. Scialla, Mirela Dobre, Jing Chen, Chi‐yuan Hsu, Mary B. Leonard, Alan S. Go, Panduranga S. Rao, James P. Lash, Raymond R. Townsend, Harold I. Feldman, Ian H. de Boer, Geoffrey A. Block, Myles Wolf, Edward R. Smith, Andreas Pasch, Tamara Isakova, Lawrence J. Appel, Harold I. Feldman, Alan S. Go, Jiang He, James P. Lash, Panduranga S. Rao, Mahboob Rahman, Raymond R. Townsend - American Journal of Kidney Diseases 2019 被引用: 99

  19. Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD

    著者: James H. Lewis, Michel Jadoul, Geoffrey A. Block, Melanie Chin, Deborah A. Ferguson, Angie Goldsberry, Colin J. Meyer, Megan A. O’Grady, Pablo E. Pérgola, Scott A. Reisman, W. Christian Wigley, Glenn M. Chertow - Clinical and Translational Science 2020 被引用: 41

  20. Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD

    著者: Anna Jovanovich, Tamara Isakova, Geoffrey A. Block, Jason R. Stubbs, Gerard Smits, Michel Chonchol, Makoto Miyazaki - American Journal of Kidney Diseases 2017 被引用: 80

  21. Use of Wastewater Metrics to Track COVID-19 in the US

    著者: Meri R.J. Varkila, Maria E. Montez‐Rath, Joshua A. Salomon, Xue Yu, Geoffrey A. Block, Douglas K Owens, Glenn M. Chertow, Julie Parsonnet, Shuchi Anand - JAMA Network Open 2023 被引用: 31

  22. Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease—Improving Global Outcomes (KDIGO) Controversies Conference

    著者: Colin Baigent, William G. Herrington, Josef Coresh, Martin Landray, Adeera Levin, Vlado Perkovic, Marc A. Pfeffer, Peter Rossing, Michael Walsh, Christoph Wanner, David C. Wheeler, Wolfgang C. Winkelmayer­, John J.V. McMurray, Ali K. Abu‐Alfa, Patrick Archdeacon, Geoffrey A. Block, Fergus Caskey, Alfred K. Cheung, Bruce A. Cooper, Jonathan C. Craig, Laura M. Dember, Garabed Eknoyan, Ron T. Gansevoort, John S. Gill, Barbara S. Gillespie, Tom Greene, David C.H. Harris, Richard Haynes, Brenda R. Hemmelgarn, Charles A. Herzog, Thomas F. Hiemstra, Lesley A. Inker, Meg Jardine, Vivekanand Jha, Lixin Jiang, Kirsten L. Johansen, Reshma Kewalramani, Hiddo J.L. Heerspink, Martin Lefkowitz, Charmaine E. Lok, Fiona Loud, Romaldas Mačiulaitis, Dugan Maddux, Franklin W. Maddux, Magdalena Madero, Segundo Mariz, Michael Mauer, Joseph V. Nally, Masaomi Nangaku, Ikechi G. Okpechi, Patrick S. Parfrey, Roberto Pecoits‐Filho, Brian J.G. Pereira, Michael V. Rocco, Patrick Rossignol, Franz Schaefer, Francesca Tentori, Aliza Thompson, Marcello Tonelli, Allison Tong, Robert D. Toto, Katherine R. Tuttle, Thorsten Vetter, Angela Yee‐Moon Wang, Faı̈ez Zannad - Kidney International 2017 被引用: 147

  23. Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial

    著者: Geoffrey A. Block, David P. Rosenbaum, Andrew T. Yan, Glenn M. Chertow - Journal of the American Society of Nephrology 2019 被引用: 119

  24. Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease

    著者: Peter Rossing, Geoffrey A. Block, Melanie Chin, Angie Goldsberry, Hiddo J.L. Heerspink, Peter A. McCullough, Colin J. Meyer, David Packham, Pablo E. Pérgola, Bruce Spinowitz, Stuart M. Sprague, David G. Warnock, Glenn M. Chertow - Kidney International 2019 被引用: 37